Chapter 7 Photosensitizers-systemic sensitization

Comprehensive Series in Photosciences

Volumn 2, Issue C, 2001, Pages 101-114

  Zane, Cristina ^a   Panfilis, Giuseppe De ^a   Calzavara Pinton, Piergiacomo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957093926     PISSN: 1568461X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1568-461X(01)80111-3     Document Type: Article

References (50)

1. Spikes J.D., and Jori G. Photodynamic therapy of tumors and other diseases using porphyrins. Laser Med. Sci. 2 (1987) 3-15
2. Malik Z., Ladan H., Ehrenber B., and Nitzan Y. Bacterial and viral inactivation. In: Henderson B.W., and Dougherty T.J. (Eds). Photodynamic therapy. Basic principles and applications (1992), Marcel Dekker Inc., New York 97-113
3. Cuomo V., Jori G., Rihter B., Kenney M.E., and Rodgers M.A.J. Liposome-derived Si(IV)-naphtalocyanine as a photodynamic sensitiser for experimental tumours: pharmacokinetic and phototherapeutic studies. Br. J. Cancer 62 (1990) 966-970
4. Kimel S.B., Tromberg J., Roberts W.G., and Berns M.W. Synglet oxygen generation of porphyrins, chlorins, and phthalocyanines. Photochem. Photobiol. 50 (1989) 175-183
5. Kostron H., Bellnier D., Lin C.W., Schwartz M.R., and Martuza R. Distribution, retention, and phototoxicity of hematoporphyrin derivative in a rat glioma. Intraneoplastic versus intraperitoneal injection. J. Neurosurg. 64 (1986) 768-774
6. Levy J.G., and Obochi M. New applications in photodynamic therapy: Introduction. Photochem. Photobiol. 64 (1996) 737-739
7. Evans S., Matthews W., Perry R., Fraker D., Norton J., and Pass H.I. Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages. J. Natl. Cancer Inst. 82 (1990) 34-39
8. Peng Q., Moan J., Farrants G., Danielsen H.E., and Rimington C. Localization of potent photosensitizers in human tumor LOX by means of laser scanning microscopy. Cancer Lett. 58 (1991) 17-27
9. Kessel D., Thompson P., Saatio K., and Nantwi K.D. Tumor localization and photosensitization by sulfonat derivatives of tetraphenylporphine. Photochem. Photobiol. 45 (1987) 787-790
10. Reddi E., Cernuschi S., Biolo R., and Jori G. Liposome-or LDL administered Zn (II)-phthalocyanine as a photodynamic agent for tumors. III. Effect of cholesterol on pharmacokinetic and phototherapeutic properties. Lasers Med. Sci. 5 (1990) 339-343
11. Reddi E., Zhou C., Biolo R., Menegaldo E., and Jori G. Liposoma-or LDL-administered Zn(II)-phthalocyanine as a photodynamic agent for tumors. I. Pharmacokinetic properties and phototherapeutic efficiency. Br. J. Cancer 61 (1990) 407-411
12. Biade S., Maziere J.C., Mora L., Santus R., Maziere C., Auclair M., Moliere P.P., and Dubertret L. Lovostatin potentiates the photocytotoxic effect of photofrin II delivered to HT29 human colonic adenocarcinoma cells by low density lipoprotein. Photochem. Photobiol. 57 (1993) 371-375
13. Bachor R., Shea C.R., Gillies R., and Hasan T. Photosensitized destruction of human bladder carcinoma cells terated with chlorin e6-conjugated microspheres. Proc. Natl. Acad. Sci. USA 88 (1991) 1580-1584
14. Schmidt-Ehrfurt U., Baumann W., Gragoudas E., Flotte T.J., Michaud N.A., Birngruber R., and Hasan T. Photodynamic therapy of experimental choroidal malanoma using lipoprotein-delivered benzoporphyrin. Ophtlmology 101 (1994) 89-99
15. Hasan T., Lin A., Yarmush D., Oseroff D., and Yarmush M. Monoclonal antibodychromophore conjugates as selective phototoxins. J. Controlled Release 10 (1989) 107-117
16. Mew D., Watt C.K., Towers G.H.N., and Levy J. Photoimmunotherapy treatment of animal tumors with tumor specific monoclonal antibody-hematoporphyrin conjugates. J. Immunol. 130 (1983) 1473-1477
17. Richter A.M., Kelly B., Chow J., Lui D.J., Towers G.N.H., Dolphin D., and Levy J.G. Preliminary studies on a more effective phototoxic agent than hematoporphyrin. J. Natl. Cancer Inst. 79 (1987) 1327-1332
18. Hasan T., Lin C.W., and Lin A. Laser-induced selective cytotoxicity using monoclonal antibody-cromophore conjugates. Prog. Clin. Biol. Res. 288 (1989) 471-477
19. H. Diddens R. Uptake and subcellular distribution of photosensitizing drugs in malignant cells. In: Hönigsmann H., Jori G., and Young A.R. (Eds). The fundamental bases of phototherapy (1996), OEMF, Milano
20. Szeimies R.M., Karrer S., Abels C., Steinbach P., Fickweiler S., Messmann H., Bäumler W., and Landthaler M. 9-acetoxy-2,7,12,17-tetrakis-(methoxyethyl)-porphycene (ATMPn) a novel photosensitizer for photodynamic therapy: uptake kinetics and intracellular localization. J. Photochem. Photobiol. B:Biol. 34 (1996) 67-72
21. Woodburn K.W., Kaye N.J., Reiss A.A., and Phillips D.R. Evaluation of porphyrin characteristics required for photodynamic therapy. Photochem. Photobiol. 55 (1992) 697-704
22. Shulok J.R., Wade M.H., and Liu C.W. Subcellular localization of hematoporphyrin derivative in bladder tumor cells in culture. Photochem. Photobiol. 51 (1990) 451-457
23. Pottier R., and Kennedy J.C. The possible role of ionic species in selective biodistribution of photochemotherapeutic agents toward neoplastic tissue. J. Photochem. Photobiol. B:Biol 8 (1990) 1-16
24. Miller G.G., Brown K., Moore R.B., Diwu Z.J., Liu J., Huang L., Lown J.W., Begg D.A., Chlumecky V., Tulip J., and McPhee M.S. Uptake kinetics and intracellular localization of hypocrellin photosensitizers for photodynamic therapy: a confocal microscopy study. Photochem. Photobiol. 61 (1995) 632-638
25. Prinzse C., Penning L.C., Dubbelmann T.M.A.R., and Van Steveninck J. Interaction of photodynamic tretament and either hyperthermia or ionizing radiation and of ionizing radiation and hyperthermia with respect to cell killing of L929 fibroblasts, chinese hamster ovary cells, and T24 human bladder cells. Cancer Res. 52 (1992) 117-120
26. Moan J., and Berg K. The phtotodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem. Photobiol. 53 (1991) 549-553
27. Moan J. On the diffusion length of singlet oxygen in cells and tissues. J. Photochem. Photobiol. 6 (1990) 343-347
28. Moliere P., Santus R., Maziere J.C., Bazin M., Kohen E., Smith K.M., and Dubertret L. Lysosomes as primary targets of photofrin II photosensitization in cultured human fibroblats: a kinetic, spectral and topographic investigation by microspectrofluorometry on single living cells. J. Cell. Pharmacol. 2 (1991) 143-151
29. Moan J., Peng Q., Evensen J.F., Berg K., Western A., and Rimington C. Photosensitizing efficiencies, tumor and cellular uptake of different photosensitizing druugs relevant for photodynamic therapy of cancer. Photochem. Photobiol. 46 (1987) 713-721
30. Parrish J.A. New concepts in therapeutic photomedicine, photochemistry and targeting and the therapeutic window. J. Invest. Dermatol. 77 (1981) 45-50
31. Wilson B.C., Jeeves W.P., Lowe D.M., and Adam G. Light propagation in anima tissues in the wavelength range 375-825 nanometers. In: Doiron D.R., and Gomer C.J. (Eds). Porphyrin Localization and treatment of tumors (1984), R. Alan, Liss Inc, New York 115-132
32. Jori G. Far-red-absorbing photosensitizers: their use in the photodynamic therapy of tumours. J. Photochem. Photobiol. A:Chem. 62 (1992) 371-378
33. Lightdale C.J., Heier S.K., Marcon N.E., McCaughan Jr. J.S., Gerdes H., Overholt B.F., Sivak Jr. M.V., Stiegmann G.V., and Nava H.R. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophagealcancer: a multicenter randomized trial. Gastrointest Endosc. 42 6 (1995) 507-512
34. Sassa S., and Kappas A. Genetic metabolic, and biochemical aspects of the porphyrias. Adv. Hum. Genet. 11 (1981) 121-231
35. Tope W.D., Ross E.V., Kollias N., Martin A., Gilles R., and Anderson R.R. Protoporphyrin IX fluorescence induced in basal cell carcinomal by oral delta-aminolevulinic acid. Photochem. Photobiol. 67 (1998) 249-255
36. Webber J., Kessel D., and Fromm D. On line fluorescence of human tissues after oral administration of 5- aminolevulinic acid. J. Photochem. Photobiol. B:Biol 38 (1997) 209-214
37. Abels C., Kuhnle G.E.H., and Goetz A.E. Photodynamic diagnosis and therapy of tumors with 5 aminolevulinic acid (ALA). Kinetics and efficacy of ALA induced porphyrins. Arch. Dermatol. Res. 287 (1995) 355
38. Gossner L., Sroka R., Hahn E.G., and Ell C. Orale gabe von 5-aminolavulinsaure zur Photodynamischen therapie von gastrointestinalen tumoren. Lasermedizin 10 (1994) 110
39. Grant E.W., Hopper C., MacRobert A.J., Speight P.M., and Bown S.G. Photodynamic therapy of orla cancer: photosensitization with systemic aminolaevulinic acid. Lancet 342 (1993) 147
40. Waterfield E.M., Renke M.E., Smits C.B., Gervais M.D., Bower R.D., Stonefield M.S., and Levy J.G. Wavelength-dependent effects of benzoporphyrin derivative monoacid ring A in vivo and in vitro. Photochem. Photobiol. 60 (1994) 383-387
41. Lui H. An overview of clinical experience with benzoporphyrin derivative for photodynamic therapy. Proc. 5th biennial IPA meeting. Amelia Island, USA (1994)
42. Chowdhary R.K., Ratkay L.G., and Canaan A.J. The use of transcutaneous photodynamic therapy in the prevention of adjiuvant-enhanced arthritis in MRL/lpr mica. Clin. Immunol. Immunopathol. 72 (1994) 255-263
43. Doiron D.R., Razum N.J., and Trommer R.M. Clinical evaluation of tin-ethyl etiopurpurin: SnET2. Proc. 5th biennial IPA meeting. Amelia Island, USA (1994)
44. Garbo G.M. Purpurins and benzochlorins as sensitizers for photodynamic therapy. J. Photochem. Photobiol. B:Biol. 34 (1996) 109-116
45. Sessler J.L., Dow W.C., O'Connor D., harriman A., Hemmi G., Mody T.D., Miller R.A., Qing F., Springs S., Woodburn K., and Young S.W. Biomedical applications of lanthanide (III) texaphyrins as potential PDT sensitizers. J. Alloys Compd. 249 (1997) 146-152
46. Sessler J.L., and Miller R.A. Texaphyrins. New drugs with diverse clinical applications in radiation and photodynamic therapy. Biochem. Pharmacol. 59 (2000) 733-739
47. Knubler A.C., Haase T., Staff C., Kahle B., Rheinwalde M., and Muhling J. Photodynamic therapy of primary nonmelanomatous skin tumors of the head and neck. Laser Surg. Med. 25 (1999) 60-68
48. Bryce R. Burns after photodynamic therapy. Br. Med. J. 320 (2000) 1731
49. Hettiaratchy S., and Clarke J. Burns after photodynamic therapy. Br. J. Derm. 320 (2000) 1245
50. Aramendia P.F., Redmond R.W., Nonell S., Schuster W., Braslavsky S.E., Scaffner K., and Vogel E. The photophysical properties of porphycenes: potential photodynamic therapy agents. Photochem. Photobiol. 44 (1986) 555-559